Programplaner og emneplaner - Student
FARB3100 Social Pharmacy, Epidemiology and Statistics Course description
- Course name in Norwegian
- Samfunnsfarmasi, epidemiologi og statistikk
- Study programme
-
Bachelor’s Programme in Pharmacy
- Weight
- 10.0 ECTS
- Year of study
- 2024/2025
- Programme description
- Course history
-
Introduction
This course covers the role of pharmaceuticals in the prevention and treatment of illness from an individual and societal perspective. Emphasis is placed on subjects in the field of social pharmacy and medicine epidemiology. Statistical concepts, epidemiology and critical assessment of articles are also covered in the course.
Required preliminary courses
The student must have passed all the courses from the first year of study and may lack a maximum of one passed course from the second year.
Learning outcomes
After completing the course, the student should have the following learning outcomes defined in terms of knowledge, skills and general competence:
Knowledge
The student
- is familiar with the routines and procedures for medication reviews and discussions
- can explain key concepts in the field of epidemiological methodology
- can explain ethical dilemmas relevant to epidemiological research
- can explain key statistical concepts in medical statistics
- is familiar with clinical testing of pharmaceuticals and the pertaining collection of and requirements relating to documentation
- is familiar with the concept of health competence and how variations in health competence influence different patients’ and user groups’ coping with disease, mastery and self-care
- is familiar with the import, economics and pricing of pharmaceuticals
- is familiar with the research processes involved in pre-clinical and clinical studies, the requirements for approval of pharmaceuticals and plant-based products and how pharmaceuticals are marketed
Skills
The student
- can apply epidemiological concepts
- can apply digital tools in statistical calculations and graphical presentations of prescription statistics and other figures that concern the use of pharmaceuticals
- can use evidence-based subject matter and innovation in project work, communicate this and contribute to professional discussions
General competence
The student
- shows an understanding of drug related problems from an individual and social perspective
- can reflect on the quality and validity of documentation from clinical trials
- can contribute to innovation and entrepreneurship as approaches to healthcare
Content
Subjects covered by the course, with credits specified:
- Social pharmacy 4 credits
- Epidemiology 3 credits
- Statistics 3 credits
Teaching and learning methods
The work and teaching methods comprise lectures, group work, project work, seminars, practical student exercises, digital teaching and work on assignments.
Course requirements
The following must have been approved in order for the student to take the exam:
- Minimum attendance of 80% in compulsory scheduled and supervised group work
- Digital storytelling in groups
- Project assignment in groups with a pitch on innovation and entrepreneurship.
Assessment
Individual oral exam, up to 30 minutes, with up to an hour's preparation
Permitted exam materials and equipment
Calculator
Grading scale
Grade scale A-F
Examiners
All answers are assessed by two examiners. An external examiner is used regularly, at a minimum of every third completion of the course. When selecting answers for external evaluation, a minimum of 10 percent of the answers shall be included, with no fewer than 5 answers. The external examiner’s assessment of the selected answers shall benefit all students.
Overlapping courses
Energieffektivisering av bygninger er et av de mest kostnadseffektive tiltak for å begrense menneskeskapt klimaendring. Passivhus-nivå har blitt standard, og det bygges flere nær-nullenergi- og pluss-hus ettersom løsninger for lokal energiforsyning (bl.a. solenergi) blir mer lønnsomme. Samtidig skjer en rivende utvikling innen digital teknologi (bl.a. simuleringsverktøy og byggautomasjon), nye byggematerialer, og nye løsninger for tekniske installasjoner, som åpner for nye muligheter. Parallelt med dette lærer vi mer fra forskning innen betydningen av inneklima for helse. Alle disse forhold gjør at byggenæringen er i rask endring, og at det stilles stadig høyere krav til de som utformer og forvalter det bygde miljø.
For å møte dagens og fremtidens utfordringer, gir masterstudiet i Energi og miljø i bygg dyptgående ingeniørfaglig kompetanse innen klimatisering (behovsstyrt varme, kjøling, ventilasjon, belysning, m.m.), energiforvaltning, og menneskelige behov (innemiljø, sanitærforhold), kombinert med kunnskap innen et bredt spektrum av temaer inkludert bygningsfysikk, numerikk, økonomi, miljøvurdering av bærekraftige løsninger, og klimatilpasning.
Masterstudiet energi og miljø i bygg kan tas som et heltidsstudium over to år eller et deltidsstudium over fire år, evt. tre år. Det søkes enten til heltids- eller deltidsstudiet. Studiet er på 120 studiepoeng og gir en fordypning og videreføring i forhold til relevante bachelorstudier.
Masterstudiet er tilrettelagt internasjonalisering i og med at deler kan gjennomføres internasjonalt ved samarbeid med utenlandsk utdanningssted.
Studiet bidrar til å løse næringens kompetansebehov og dette gjenspeiles i undervisningen. Næringslivssamarbeid vektlegges ved planlegging, gjennomføring og evaluering av studieaktiviteter.